PAVmed (PAVM) Shares Outstanding (2015 - 2025)

PAVmed's Shares Outstanding (Entity) history runs 11 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 481.41% year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a 481.41% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 481.41% from the prior year.
• Shares Outstanding (Entity) climbed to $2.2 million in Q4 2025 per PAVM's latest filing, from $768373.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $2.2 million in Q4 2025 and bottomed at $180935.0 in Q1 2021.
• The 5-year median for Shares Outstanding (Entity) is $241183.0 (2023), against an average of $401123.4.
• Across the five-year window, Shares Outstanding (Entity) increased 5.38% in 2022 and surged 481.41% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $191919.0 in 2021, then grew by 9.43% to $210013.0 in 2022, then surged by 36.14% to $285922.0 in 2023, then surged by 30.55% to $373262.0 in 2024, then jumped by 481.41% to $2.2 million in 2025.
• Per Business Quant, the three latest PAVM Shares Outstanding (Entity) figures stand at $2.2 million (Q4 2025), $768373.0 (Q3 2025), and $671348.0 (Q2 2025).